[{"orgOrder":0,"company":"ReGenTree","sponsor":"RegeneRx Biopharmaceuticals","pharmaFlowCategory":"DU","therapeuticArea":"Ophthalmology","country":"U.S.A","productType":"Protein","year":"2021","type":"Inapplicable","leadProduct":"Timbetasin Acetate","moa":"Angiopoietin-1","graph1":"Ophthalmology","graph2":"Phase III","graph3":"ReGenTree","amount2":0,"highestDevelopmentShortName":"Ph III","therapeuticAreaShortName":"Ophthalmology","amount2New":0,"dosageForm":"Ophthalmic Solution","sponsorNew":"ReGenTree \/ ReGenTree","highestDevelopmentStatusID":"10","companyTruncated":"ReGenTree \/ ReGenTree"},{"orgOrder":0,"company":"ReGenTree","sponsor":"RegeneRx Biopharmaceuticals","pharmaFlowCategory":"D","therapeuticArea":"Ophthalmology","country":"U.S.A","productType":"Protein","year":"2020","type":"Financing","leadProduct":"Timbetasin Acetate","moa":"Angiopoietin-1","graph1":"Ophthalmology","graph2":"Phase III","graph3":"ReGenTree","amount2":0,"highestDevelopmentShortName":"Ph III","therapeuticAreaShortName":"Ophthalmology","amount2New":0,"dosageForm":"Ophthalmic Solution","sponsorNew":"ReGenTree \/ ReGenTree","highestDevelopmentStatusID":"10","companyTruncated":"ReGenTree \/ ReGenTree"},{"orgOrder":0,"company":"ReGenTree","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Ophthalmology","country":"U.S.A","productType":"Protein","year":"2021","type":"Inapplicable","leadProduct":"Timbetasin Acetate","moa":"Angiopoietin-1","graph1":"Ophthalmology","graph2":"Phase III","graph3":"ReGenTree","amount2":0,"highestDevelopmentShortName":"Ph III","therapeuticAreaShortName":"Ophthalmology","amount2New":0,"dosageForm":"Ophthalmic Solution","sponsorNew":"ReGenTree \/ Inapplicable","highestDevelopmentStatusID":"10","companyTruncated":"ReGenTree \/ Inapplicable"},{"orgOrder":0,"company":"ReGenTree","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Ophthalmology","country":"U.S.A","productType":"Protein","year":"2020","type":"Inapplicable","leadProduct":"Timbetasin Acetate","moa":"Angiopoietin-1","graph1":"Ophthalmology","graph2":"Phase III","graph3":"ReGenTree","amount2":0,"highestDevelopmentShortName":"Ph III","therapeuticAreaShortName":"Ophthalmology","amount2New":0,"dosageForm":"Ophthalmic Solution","sponsorNew":"ReGenTree \/ Inapplicable","highestDevelopmentStatusID":"10","companyTruncated":"ReGenTree \/ Inapplicable"},{"orgOrder":0,"company":"ReGenTree","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Ophthalmology","country":"U.S.A","productType":"Protein","year":"2020","type":"Inapplicable","leadProduct":"Timbetasin Acetate","moa":"Angiopoietin-1","graph1":"Ophthalmology","graph2":"Phase III","graph3":"ReGenTree","amount2":0,"highestDevelopmentShortName":"Ph III","therapeuticAreaShortName":"Ophthalmology","amount2New":0,"dosageForm":"Ophthalmic Solution","sponsorNew":"ReGenTree \/ Inapplicable","highestDevelopmentStatusID":"10","companyTruncated":"ReGenTree \/ Inapplicable"},{"orgOrder":0,"company":"ReGenTree","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Ophthalmology","country":"U.S.A","productType":"Protein","year":"2020","type":"Inapplicable","leadProduct":"Timbetasin Acetate","moa":"Angiopoietin-1","graph1":"Ophthalmology","graph2":"Phase III","graph3":"ReGenTree","amount2":0,"highestDevelopmentShortName":"Ph III","therapeuticAreaShortName":"Ophthalmology","amount2New":0,"dosageForm":"Ophthalmic Solution","sponsorNew":"ReGenTree \/ Inapplicable","highestDevelopmentStatusID":"10","companyTruncated":"ReGenTree \/ Inapplicable"},{"orgOrder":0,"company":"ReGenTree","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Ophthalmology","country":"U.S.A","productType":"Protein","year":"2022","type":"Inapplicable","leadProduct":"Timbetasin Acetate","moa":"Actin (ACT)","graph1":"Ophthalmology","graph2":"Phase III","graph3":"ReGenTree","amount2":0,"highestDevelopmentShortName":"Ph III","therapeuticAreaShortName":"Ophthalmology","amount2New":0,"dosageForm":"Solution","sponsorNew":"ReGenTree \/ Inapplicable","highestDevelopmentStatusID":"10","companyTruncated":"ReGenTree \/ Inapplicable"}]

Find Clinical Drug Pipeline Developments & Deals by ReGenTree

ReGenTree
Drugs in Dev.
Full Screen View

Weekly News Recap
#Phispers

Stock Recap
#PipelineProspector

cayman pipeline prospector

Contact Supplier

Check all FDF Dossiers for
this supplier

Contact Us
PharmaScopic.com

ReGenTree

VISIT THE VIRTUAL BOOTH, Contact Details

DIGITAL CONTENT

Interview #SpeakPharma, Vlog #PharmaReel, Data Compilation #PharmaFlow, 2 News #PharmaBuzz

DEVELOPMENTS

12 Drugs in Development

12 Drugs in Development

REF. STANDARDS & IMPURITIES

1 Others

1 Others

Xls

Filters

×

filter

Company Name

filter

Year

filter

DEALS // DEV.

filter

Country

filter

Sponsor

filter

Therapeutic Area

filter

Study Phase

filter

Deal Type

filter

Product Type

filter

Dosage Form

filter

Lead Product

filter

Target

All Developments

Therapeutic Area by Lead Product

Study Phase by Lead Product

Company by Lead Product

Top Deals by Deal Size (USD bn)

Reset All

01

ReGenTree

U.S.A

ChemOutsourcing

Not Confirmed

02

ReGenTree

U.S.A

ChemOutsourcing

Not Confirmed

03

ReGenTree

U.S.A

ChemOutsourcing

Not Confirmed

04

ReGenTree

U.S.A

ChemOutsourcing

Not Confirmed

05

ReGenTree

U.S.A

ChemOutsourcing

Not Confirmed

06

ReGenTree

U.S.A

ChemOutsourcing

Not Confirmed

07

ReGenTree

U.S.A

ChemOutsourcing

Not Confirmed

08

ReGenTree

U.S.A

ChemOutsourcing

Not Confirmed

09

ReGenTree

U.S.A

ChemOutsourcing

Not Confirmed

10

ReGenTree

U.S.A

ChemOutsourcing

Not Confirmed

1
2